Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/1999
06/17/1999WO1999029853A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999WO1999029849A1 G-protein coupled receptors associated with immune response
06/17/1999WO1999029839A1 Grafted copolymers as gene carriers
06/17/1999WO1999029721A1 Anti-pathogen system and methods of use thereof
06/17/1999WO1999029662A2 Urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof
06/17/1999WO1999029657A1 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
06/17/1999WO1999029347A1 Pharmaceutical combination with analgesic activity, containing an adenosinergic agonist and a compound selected from opiates, benzodiazepines and nmda antagonists
06/17/1999WO1999029346A1 Pharmaceutical composition for treating cerebral apoplexy and craniocerebral trauma
06/17/1999WO1999029339A2 Prevention and/or treatment of allergic conditions
06/17/1999WO1999029329A1 Immunotherapy using ie water
06/17/1999WO1999029323A1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
06/17/1999WO1999029321A1 Inhibition of membrane-associated viral replication
06/17/1999WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
06/17/1999WO1999029314A1 Novel salts of metformin and method
06/17/1999WO1999029312A1 Methods for treatment of neuro- and nephro-disorders and therapeutic toxicities using aminothiol compounds
06/17/1999WO1999029308A2 Method for combating obesity
06/17/1999WO1999029173A1 Composition useful for providing one-step surgical preparation and drape
06/17/1999WO1999017796A3 Modulation of lerk-2-mediated cell adhesion
06/17/1999WO1999017742A3 Taste masked formulations
06/17/1999WO1999016887A3 Compositions and methods for identifying pkb kinase inhibitors
06/17/1999WO1999016460A3 Apolipoprotein e/growth factor complexes and methods of use
06/17/1999WO1999016420A9 Stabilized preparations for use in nebulizers
06/17/1999WO1998056919A3 Methods and reagents for vaccination which generate a cd8 t cell immune response
06/17/1999DE19754795A1 Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation
06/17/1999CA2314267A1 Anti-pathogen system and methods of use thereof
06/17/1999CA2313451A1 Cyclic gmp phosphodiesterase
06/17/1999CA2313450A1 G-protein coupled receptors associated with immune response
06/17/1999CA2313236A1 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides, corresponding acids, and uses
06/17/1999CA2312760A1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
06/17/1999CA2312697A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999CA2312423A1 Inhibition of membrane-associated viral replication
06/17/1999CA2311681A1 Human interferon-epsilon: a type i interferon
06/17/1999CA2310381A1 Method and cells to screen combinatorial libraries
06/17/1999CA2309686A1 Composition useful for providing one-step surgical preparation and drape
06/16/1999EP0922762A1 Drug binding protein
06/16/1999EP0922760A2 Transgenic animal not expressing endogenous osteoclastogenesis inhibitory factor (OCIF)
06/16/1999EP0922458A1 Potentiation of temozolomide by an ATase inhibitor
06/16/1999EP0922454A2 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
06/16/1999EP0922102A1 Hepatocyte growth factor receptor agonists and uses thereof
06/16/1999EP0922029A1 Ether muscarinic antagonists
06/16/1999EP0921822A1 Animal model for transplantation
06/16/1999EP0921818A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
06/16/1999EP0921816A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
06/16/1999EP0921811A2 Administration of histamine for therapeutic purposes
06/16/1999EP0921810A2 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
06/16/1999EP0921798A1 Novel treatment of leptine resistance
06/16/1999EP0848736A4 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor
06/16/1999EP0633764B1 Skin care method and composition
06/16/1999EP0316434B2 Cough/cold mixtures comprising non-sedating antihistamine drugs
06/16/1999CN1219965A Promotion of regeneration of organized tissues
06/16/1999CN1219872A Compositions and method for treating or preventing diseases of body passageways
06/16/1999CN1219392A Anti-inflammatory pharmaceutical compositions
06/15/1999US5912335 A polynucleotide sequence that codes human 7-transmembrane receptor protein; treatment of infections, hiv, eating disorders, cancers, heart diseases, mental illnesses, huntington's disease, tourett's and parkinson's disease
06/15/1999US5912271 Local anaesthetic agents, a polar lipid, a triacylglycerol and optionally water.
06/15/1999US5912250 Use of immunosuppressive agents for the treatment of schizophrenia
06/15/1999US5912228 Mixture with ethylene oxide-propylene oxide block copolymer and ethylenediaminetetraacetic acid
06/15/1999US5912144 A polypeptide having an amino acid sequence for an immediate early response gene/g protein couplec receptor; anticarcinogenic, antiproliferative and antitumor agents
06/15/1999US5912143 Polynucleotides encoding a human mage protein homolog
06/15/1999US5912123 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
06/15/1999US5912122 A polynucleotide coding for a central nervous system g protein receptor; therapy for neurodegenerative disorders
06/15/1999US5912010 Prophylactic and therapeutic treatment of skin sensitization and irritation
06/10/1999WO1999028745A1 Identification and characterization of interacting molecules by automated interaction mating
06/10/1999WO1999028744A1 Identification and characterization of interacting molecules
06/10/1999WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51
06/10/1999WO1999028492A1 A method of finding agonist and antagonist to human 11cb splice variant
06/10/1999WO1999028440A1 Nucleic acid encoding mammalian ubr1
06/10/1999WO1999028342A2 Low-voltage activated calcium channel compositions and methods
06/10/1999WO1999027962A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999WO1999027927A1 Synergistic antimicrobial compositions
06/10/1999WO1999027923A1 Agents for combating neospora spec
06/10/1999WO1999027919A2 Cyp2a enzymes and their use in therapeutic and diagnostic methods
06/10/1999WO1999027908A1 Combined chemo-immunotherapy with liposomal drugs and cytokines
06/10/1999WO1999027906A1 Long acting injectable formulations containing hydrogenated castor oil
06/10/1999WO1999027905A1 Compositions for nasal administration
06/10/1999WO1999013095A3 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/10/1999WO1999009964A3 Pharmaceutical composition containing clindamycin and clotrimazol for treating vaginal infections
06/10/1999WO1999007737A3 Lsr receptor, cloning and uses
06/10/1999DE19754573A1 Pharmazeutische Zusammensetzung zur Behandlung von Schlaganfall und Schädel-Hirn-Trauma A pharmaceutical composition for the treatment of stroke and traumatic brain injury
06/10/1999DE19754082A1 Methode zur Bekämpfung der Fettleibigkeit Method to combat obesity
06/10/1999DE19753504A1 Mittel zur Bekämpfung von Neospora spec Means of combating Neospora spec
06/10/1999DE19753383A1 Verwendung von Abciximab zur Behandlung von Mikrozirkulationsstörungen Use of abciximab for treatment of microcirculatory disorders
06/10/1999CA2313243A1 Nucleic acid encoding mammalian ubr1
06/10/1999CA2312851A1 Therapeutic and diagnostic methods dependent on cyp2a enzymes
06/10/1999CA2312824A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999CA2312811A1 Synergistic antimicrobial compositions
06/10/1999CA2312778A1 Combined chemo-immunotherapy with liposomal drugs and cytokines
06/10/1999CA2312396A1 Agents for combating neospora spec
06/10/1999CA2312195A1 Low-voltage activated calcium channel compositions and methods
06/10/1999CA2311927A1 Identification and characterization of interacting molecules
06/10/1999CA2311705A1 Identification and characterization of interacting molecules by automated interaction mating
06/09/1999EP0921197A2 Human disintegrin metalloprotease related to drosophila kuz gene
06/09/1999EP0920865A1 Pharmaceutical compositions containing Norastemizole
06/09/1999EP0920864A1 Combination therapy including a specific beta-3 agonist and an anorectic agent
06/09/1999EP0920632A1 Materials and methods for detection and treatment of immune system dysfunctions
06/09/1999EP0920530A1 Screening methods using microbial strain pools
06/09/1999EP0920518A1 Stimulus-inducible i (kappa)b kinase ikk] signalsome
06/09/1999EP0920506A1 Human dbi/acbp-like protein
06/09/1999EP0920503A2 A novel human leptin receptor gene-related protein
06/09/1999EP0920494A2 Pro-protein converting enzyme
06/09/1999EP0920315A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
1 ... 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 ... 1151